Jens Duebel1, Katia Marazova, José-Alain Sahel. 1. aInstitut de la Vision, Sorbonne Universités, UPMC Univ Paris, UMR_S 968 bINSERM, U_968 cCNRS, UMR_7210 dCentre Hospitalier National d'Ophtalmologie des Quinze-Vingts, DHU ViewMaintain, INSERM-DHOS CIC 1423 eFondation Ophtalmologique Rothschild, Paris, France fInstitute of Ophthalmology-University College London, London, UK.
Abstract
PURPOSE OF REVIEW: In this review, we will discuss the recent developments in optogenetics and their potential applications in ophthalmology to restore vision in retinal degenerative diseases. RECENT FINDINGS: In recent years, we have seen major advances in the field of optogenetics, providing us with novel opsins for potential applications in the retina. Microbial opsins with improved light sensitivity and red-shifted action spectra allow optogenetic stimulation at light levels well below the safety threshold in the human eye. In parallel, remarkable success in the development of highly efficient viral vectors for ocular gene therapy led to new strategies of using these novel optogenetic tools for vision restoration. SUMMARY: These recent findings show that novel optogenetic tools and viral vectors for ocular gene delivery are now available providing many opportunities to develop potential optogenetic strategies for vision restoration.
PURPOSE OF REVIEW: In this review, we will discuss the recent developments in optogenetics and their potential applications in ophthalmology to restore vision in retinal degenerative diseases. RECENT FINDINGS: In recent years, we have seen major advances in the field of optogenetics, providing us with novel opsins for potential applications in the retina. Microbial opsins with improved light sensitivity and red-shifted action spectra allow optogenetic stimulation at light levels well below the safety threshold in the human eye. In parallel, remarkable success in the development of highly efficient viral vectors for ocular gene therapy led to new strategies of using these novel optogenetic tools for vision restoration. SUMMARY: These recent findings show that novel optogenetic tools and viral vectors for ocular gene delivery are now available providing many opportunities to develop potential optogenetic strategies for vision restoration.
Authors: Georg Nagel; Tanjef Szellas; Wolfram Huhn; Suneel Kateriya; Nona Adeishvili; Peter Berthold; Doris Ollig; Peter Hegemann; Ernst Bamberg Journal: Proc Natl Acad Sci U S A Date: 2003-11-13 Impact factor: 11.205
Authors: Adam M Packer; Darcy S Peterka; Jan J Hirtz; Rohit Prakash; Karl Deisseroth; Rafael Yuste Journal: Nat Methods Date: 2012-11-11 Impact factor: 28.547
Authors: Xue Han; Brian Y Chow; Huihui Zhou; Nathan C Klapoetke; Amy Chuong; Reza Rajimehr; Aimei Yang; Michael V Baratta; Jonathan Winkle; Robert Desimone; Edward S Boyden Journal: Front Syst Neurosci Date: 2011-04-13
Authors: Mariacarmela Allocca; Claudio Mussolino; Maria Garcia-Hoyos; Daniela Sanges; Carolina Iodice; Marco Petrillo; Luk H Vandenberghe; James M Wilson; Valeria Marigo; Enrico M Surace; Alberto Auricchio Journal: J Virol Date: 2007-08-15 Impact factor: 5.103
Authors: Robert E MacLaren; Markus Groppe; Alun R Barnard; Charles L Cottriall; Tanya Tolmachova; Len Seymour; K Reed Clark; Matthew J During; Frans P M Cremers; Graeme C M Black; Andrew J Lotery; Susan M Downes; Andrew R Webster; Miguel C Seabra Journal: Lancet Date: 2014-01-16 Impact factor: 79.321
Authors: Matthew M LaVail; Shimpei Nishikawa; Roy H Steinberg; Muna I Naash; Jacque L Duncan; Nikolaus Trautmann; Michael T Matthes; Douglas Yasumura; Cathy Lau-Villacorta; Jeannie Chen; Ward M Peterson; Haidong Yang; John G Flannery Journal: Exp Eye Res Date: 2017-11-06 Impact factor: 3.467
Authors: Tomas S Aleman; Grace Han; Leona W Serrano; Nicole M Fuerst; Emily S Charlson; Denise J Pearson; Daniel C Chung; Anastasia Traband; Wei Pan; Gui-Shuang Ying; Jean Bennett; Albert M Maguire; Jessica I W Morgan Journal: Ophthalmology Date: 2016-12-13 Impact factor: 12.079
Authors: Matthew A Boehm; Jordi Bonaventura; Juan L Gomez; Oscar Solís; Elliot A Stein; Charles W Bradberry; Michael Michaelides Journal: Pharmacol Biochem Behav Date: 2021-02-04 Impact factor: 3.533
Authors: Ratnesh K Singh; Francois Binette; Magdalene Seiler; Simon M Petersen-Jones; Igor O Nasonkin Journal: J Ocul Pharmacol Ther Date: 2020-10-14 Impact factor: 2.671